# US 2026/0092928 A1 · Methods of analyzing heterodimeric ¿proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092928 A1
- Document ID: US20260092928A1
- Status: Published application
- Kind: A1
- Application number: 19/345,737
- Filed: 2025-09-30
- Published: 2026-04-02
- Earliest claimed: 2024-10-01
- Assignees: Regeneron Pharmaceuticals, Inc.
- Applicants: Regeneron Pharmaceuticals, Inc.
- Inventors: Pallavi PRASAD; Jiann-Kae Luo; Svetlana Schussler; Michelle Mazzeo; Michael Perrone
- Web page: https://patentgrep.com/patent/US20260092928A1

## CPC

- G01N 33/6854: {Immunoglobulins}
- B01D 15/1885: {placed in parallel}
- B01D 15/3809: {of the antigen-antibody type, e.g. protein A, G or L chromatography}
- B01D 15/426: {Specific type of solvent}
- B01J 20/24: Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
- B01J 20/28004: {Sorbent size or size distribution, e.g. particle size}
- B01J 20/28085: {being more than 50 nm, i.e. macropores}
- B01J 20/285: based on polymers
- B01J 20/288: Polar phases
- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- G01N 30/14: by elimination of some components
- G01N 30/8631: {Peaks}
- G01N 30/88: Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N 2030/8831: {involving peptides or proteins}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present disclosure provides methods for analyzing a mixture of proteins using affinity chromatography. In some embodiments, the proteins are heterodimeric bispecific antibodies or antigen-binding fragments thereof. In some embodiments, guanidinium salts are used in the mobile phase of the affinity chromatography. This disclosure provides protein analysis methods that provide superior resolution and lower machine maintenance than other methods.

## Claims

### Claim 1

A method of analyzing a heterodimeric protein in a mixture comprising the heterodimeric protein and impurities, the method comprising:
(a) loading an affinity matrix containing a protein-binding ligand with a sample of the mixture, wherein the heterodimeric protein comprises first and second polypeptides with differing affinities for the protein-binding ligand, and wherein at least one impurity binds the protein-binding ligand with greater affinity than the heterodimeric protein and at least one impurity does not bind the protein-binding ligand or binds with lower affinity than the heterodimeric protein;
(b) washing the mixture on the affinity matrix with a first mobile phase comprising a guanidinium salt at a concentration of from 50 mM to 300 mM;
(c) eluting the heterodimeric protein in an eluate from the affinity matrix with a second mobile phase comprising an elution buffer; and
(d) quantitating the heterodimeric protein in the eluate.

### Claim 2 (depends on 1)

The method of claim 1, wherein the heterodimeric protein is a bispecific antibody or an antigen-binding fragment thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the impurities comprise homodimeric proteins.

### Claim 4 (depends on 1)

The method of claim 1, wherein the guanidinium salt is a guanidinium cation paired with an anion selected from the group consisting of SO42−, HPO42−, acetate−, citrate−, Cl−, NO3−, ClO3−, I−, ClO4−, and SCN−.

### Claim 5 (depends on 1)

The method of claim 1, wherein the guanidinium salt is guanidinium chloride.

### Claim 6 (depends on 1)

The method of claim 1, wherein the concentration of the guanidinium salt is 50 to 250 mM, about 50 mM, about 100 mM, about 150 mM, about 200 mM, or about 250 mM.

### Claim 7 (depends on 1)

The method of claim 1, wherein the first mobile phase further comprises a buffer.

### Claim 8 (depends on 7)

The method of claim 7, wherein the buffer is sodium acetate.

### Claim 9 (depends on 7)

The method of claim 7, wherein the buffer is at a concentration of from 100 mM to 300 mM.

### Claim 10 (depends on 7)

The method of claim 7, wherein the buffer is sodium acetate at a concentration of about 200 mM.

### Claim 11 (depends on 7)

The method of claim 7, wherein the first mobile phase has a pH of 8-9, or about 8.5.

### Claim 12 (depends on 1)

The method of claim 1, wherein the elution buffer contains an acid.

### Claim 13 (depends on 12)

The method of claim 12, wherein the acid is acetic acid, or wherein the elution buffer has a pH between 1 and 3.

### Claim 14 (depends on 12)

The method of claim 12, wherein the acetic acid is at a concentration of from 100 mM to 1 M, or wherein the acetic acid is at a concentration of about 500 mM.

### Claim 15 (depends on 1)

The method of claim 1, wherein the second mobile phase has a pH of from 3.5-5, 4-4.5, or 4.1-4.4.

### Claim 16 (depends on 1)

The method of claim 1, wherein the protein-binding ligand is Protein A, and the first affinity matrix comprises a Protein A ligand affixed to a substrate.

### Claim 17

(canceled)

### Claim 18 (depends on 1)

The method of claim 1, further comprising a second affinity matrix.

### Claim 19

(canceled)

### Claim 20 (depends on 18)

The method of claim 18, wherein the second affinity matrix comprises a second protein-binding ligand, and the affinity matrix comprises a Protein G ligand affixed to a substrate Protein G.

### Claim at position 21

-32. (canceled)

### Claim 33

A method of analyzing a heterodimeric protein in a mixture comprising the heterodimeric protein and impurities, the method comprising:
(a) loading an affinity matrix containing Protein A with a sample of the mixture, wherein the heterodimeric protein comprises first and second polypeptides with differing affinities for Protein A, and wherein at least one impurity binds the Protein A with greater affinity than the heterodimeric protein and at least one impurity does not bind the Protein A or binds the Protein A with lower affinity than the heterodimeric protein;
(b) washing the mixture on the affinity matrix with a first mobile phase comprising guanidinium chloride and a buffer, wherein the guanidinium chloride is at a concentration of from 50 mM to 250 mM, and wherein the buffer is sodium acetate at a concentration of from 150 mM to 250 mM; and
(c) eluting the heterodimeric protein from the affinity matrix in an eluate with a second mobile phase comprising an elution buffer, wherein the elution buffer is acetic acid at a concentration of from 450 mM to 550 mM, and wherein the second mobile phase has a pH of 4.0 to 4.5; and
(d) quantitating the heterodimeric protein in the eluate.

### Claim 34

(canceled)

### Claim 35

A method of analyzing a heterodimeric protein and two types of homodimeric proteins in a mixture comprising the heterodimeric protein and the two types of homodimeric proteins, the method comprising:
(a) loading a first affinity matrix containing a first protein-binding ligand with a sample of the mixture, wherein the heterodimeric protein comprises first and second polypeptides with differing affinities for the first protein-binding ligand, wherein a first type of homodimeric protein binds the protein-binding ligand with greater affinity than the heterodimeric protein and a second type of homodimeric protein does not bind the protein-binding ligand or binds with lower affinity than the heterodimeric protein, and wherein the first protein-binding ligand is Protein A;
(b) loading a second affinity matrix containing a second protein-binding ligand with a sample of the mixture, wherein the second type of homodimeric protein binds the second protein-binding ligand with greater affinity than the heterodimeric protein, and wherein the second protein-binding ligand is Protein G;
(c) washing the mixture on the affinity matrix with a first mobile phase comprising a guanidinium salt at a concentration of from 50 mM to 300 mM and a buffer, wherein the buffer is sodium acetate at a concentration of from 100 to 300 mM sodium acetate;
(d) eluting the heterodimeric protein and the first type of homodimeric protein from the first affinity matrix with a second mobile phase comprising an elution buffer, wherein the elution buffer comprises acetic acid at a concentration of from 300 mM to 700 mM mixed with the first mobile phase in increasing volumes to decrease pH of the first mobile phase over time;
(e) eluting the second type of homodimeric protein from the second affinity matrix; and
(f) quantitating the first type of homodimeric protein, the heterodimeric protein, and the second type of homodimeric protein.

### Claim at position 25

-41. (canceled)
